Goldman Sachs Group Inc Anixa Biosciences Inc Transaction History
Goldman Sachs Group Inc
- $555 Billion
- Q1 2024
A detailed history of Goldman Sachs Group Inc transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 20,501 shares of ANIX stock, worth $49,817. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,501Holding current value
$49,817% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding ANIX
# of Institutions
59Shares Held
5.16MCall Options Held
14.5KPut Options Held
24.3K-
Vanguard Group Inc Valley Forge, PA1.39MShares$3.38 Million0.0% of portfolio
-
Laird Norton Trust Company, LLC604KShares$1.47 Million0.26% of portfolio
-
Ubs Group Ag536KShares$1.3 Million0.0% of portfolio
-
Mission Wealth Management, LP502KShares$1.22 Million0.04% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA341KShares$828,5100.0% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $74.5M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...